Background
The human GRIN1/GRIN2D genes encode an N-methyl-D-aspartate receptor belonging to the ionotropic glutamate receptor family. NMDA receptors expressed in neurons are therapeutic targets in treatment of neurological disorders.
| General Info | |
| Synonyms | GluN1/GluN2D |
|---|---|
| Product Description | Human NMDA (NR1/NR2D) Receptor-expressing, stable replicating cell line. |
| Target Type | Ion Channel |
| Product Type | Replicating Cell Line |
| Family | Ligand-Gated |
| Receptor | Glutamate |
| Sub-Type | NMDA (NR1/NR2D) |
| Class | Ligand-gated cation channel |
| Therapeutic Area | neurodegeneration & stroke |
| Related Services | Large-scale Cryopreservation |
| Gene Name | GRIN1/GRIN2D |
| Validated Assay/Platform | FLIPR® |
| References | Danysz W and Parsons CG. 1998. Glycine and N-methyl-d-aspartate receptors: Physiological significance and possible therapeutic applications. Pharmacol Rev. 50:597-664. |
| Host cell | HEK293 |
| Mycoplasma Status | Negative (MycoAlert Kit) |
| Storage & Packaging | |
| Packaging | Cryopreserved cells, 2-3x106 cells |
| Storage Recommendation | liquid nitrogen |
| Quantity | 2-3 million cells |
| Product Documentation | |
| Specification Sheet | |



